Lead sponsor
T3D Therapeutics, Inc.
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
1
Ongoing
662
Total enrollment
5
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1/2
1
Phase 2
1
Phase 2/3
1
Trials by status
Not yet recruiting
1
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjectsmild-to-moderate ADPh 2/3Not yet recruiting376
Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjectsmild-to-moderate ADPh 2Completed250
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Diseasemild-to-moderate ADPh 1/2Completed36